A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that ...

The Zensights Federated Healthcare Advisory Panel explores how shifting global dynamics are reshaping access and strategic planning across the healthcare system. The second day of Asembia’s AXS25 ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have the potential to improve patient access to care, along with the work needed to generate ...

The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled ...